Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
Professor Anne Alstott of Yale Law School and Dr. Meredithe McNamara of the Yale School of Medicine, the co-founders of The Integrity Project at Yale Law School, have co-authored a white paper with a team of international scientists that takes an expert, evidence-based approach to discussing key
Submission date: End of financial year 2023 - 2024
ADAPT is an oral immunotherapy program offered at participating hospitals to eligible babies with peanut allergy. Peanut is the most common cause of childhood food allergy, affecting 3.1 per cent of one-year-olds in Australia. Oral immunotherapy (OIT) is an emerging treatment option that aims to
Babies with peanut allergies in Australia will be offered a treatment program under a world-first model aiming to transform allergy care. Ten paediatric hospitals across five states have partnered with the National Allergy Centre of Excellence (NACE), hosted at Murdoch Children’s Research
Page 32 of 207
